COVID-19 Vaccine Demand and Financial Incentives
- 5 October 2021
- journal article
- research article
- Published by Springer Nature in Applied Health Economics and Health Policy
- Vol. 19 (6) , 871-883
Abstract
Background Public health experts estimate that only very high COVID-19 vaccine uptake levels can result in herd immunity. Objective This study’s main objective was to evaluate the impact of vaccine price levels, including payments, and the efficacy levels on COVID-19 vaccine demand. Methods Data for this study were collected from an online survey of 2000 US individuals aged 18 years and older, which included a set of contingent valuation questions. Parametric and nonparametric procedures were used to estimate the distribution of willingness-to-pay and willingness-to-accept values for the vaccine and to assess its association with vaccine efficacy levels (50, 70, and 95%). Results Most of the individuals (60%) indicated they were willing to pay a positive amount for the vaccine; 13.7% said they would only accept the vaccine if it were free; 14.1% were willing to take the vaccine only if they were paid; and 12.2% were not willing to accept the vaccine. The vaccine efficacy level was found to affect an individual’s demand for the vaccine. Estimated mean willingness-to-pay values were: US$594, US$706, and US$723 for vaccines with efficacy levels of 50, 70, and 95%, respectively. Conclusions US individuals highly value the COVID-19 vaccine, and about 88% of the US population would accept the vaccination; however, 14% indicated they would get vaccinated if compensated. Payments of about US$500 or more would be needed to sufficiently incentivize 50% or more of this group vaccinated.Keywords
Funding Information
- Texas Tech University
This publication has 32 references indexed in Scilit:
- Optimal Design of Population-Level Financial Incentives of Influenza Vaccination for the ElderlyValue in Health, 2020
- Attention, intentions, and follow-through in preventive health behavior: Field experimental evidence on flu vaccinationJournal of Economic Behavior & Organization, 2015
- Correction: A Multi-country Study of the Household Willingness-to-Pay for Dengue Vaccines: Household Surveys in Vietnam, Thailand, and ColombiaPLOS Neglected Tropical Diseases, 2015
- Determinants of willingness to pay for self-paid vaccines in ChinaVaccine, 2014
- [Parents willingness to pay for a human papillomavirus vaccine to protect their adolescent daughters: Maule Region, Chile].2014
- Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014Eurosurveillance, 2014
- Disposición de los padres a pagar por una vacuna contra el virus del papiloma humano para sus hijas adolescentes. Región del Maule, ChileSalud Pública de México, 2014
- Public Acceptance and Willingness-to-Pay for a Future Dengue Vaccine: A Community-Based Survey in Bandung, IndonesiaPLOS Neglected Tropical Diseases, 2013
- Design of Sequential Experiments for Contingent Valuation StudiesJournal of Environmental Economics and Management, 1993
- The Empirical Distribution Function with Arbitrarily Grouped, Censored and Truncated DataJournal of the Royal Statistical Society Series B: Statistical Methodology, 1976